"Designing Growth Strategies is in our DNA"

U.S. Biosimilar Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies and Others), By Disease Indication (Caner, Auto Immune Diseases (Arthritis, Psoriasis, Neutropenia, and others), and Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast, 2020-2027

The United States biosimilar market size was valued at USD 737.2 million in 2019 and is projected to reach USD 22,966 million by 2027, exhibiting a CAGR of 46.2% during t... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : United States | Published Date: Aug, 2020 | Report ID: FBI100990 | Status : Published

 

Request Sample PDF

Refresh Button
U.S. Biosimilars Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2019
  • 2016-2018
  • 96
  • Direct Purchase
  • 2850
    4850
    6850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X